These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2889813

  • 1. Beta-blockers in hypertension.
    Hansson L.
    J Hypertens Suppl; 1987 Aug; 5(3):S61-7. PubMed ID: 2889813
    [Abstract] [Full Text] [Related]

  • 2. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ, Schalekamp MA.
    Postgrad Med J; 1983 Aug; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [Abstract] [Full Text] [Related]

  • 3. Beta-adrenergic blocking agents in the treatment of hypertension. Choices based on pharmacological properties and patient characteristics.
    Wallin JD, Shah SV.
    Arch Intern Med; 1987 Apr; 147(4):654-9. PubMed ID: 2881524
    [Abstract] [Full Text] [Related]

  • 4. [Do beta-blockers prevent coronary events in hypertensive patients?].
    Diévart F, Ragot S, Julien J, Herpin D.
    Arch Mal Coeur Vaiss; 2005 Sep; 98(9):881-8. PubMed ID: 16231574
    [Abstract] [Full Text] [Related]

  • 5. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA.
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [Abstract] [Full Text] [Related]

  • 6. Beta-blockers, dyslipidemia, and coronary artery disease. A reassessment.
    Burris JF.
    Arch Intern Med; 1993 Sep 27; 153(18):2085-92. PubMed ID: 8104394
    [Abstract] [Full Text] [Related]

  • 7. Are we misunderstanding beta-blockers.
    Cruickshank JM.
    Int J Cardiol; 2007 Aug 09; 120(1):10-27. PubMed ID: 17433471
    [Abstract] [Full Text] [Related]

  • 8. Beta-blockers in the treatment of hypertension: are there clinically relevant differences?
    Weir MR.
    Postgrad Med; 2009 May 09; 121(3):90-8. PubMed ID: 19491545
    [Abstract] [Full Text] [Related]

  • 9. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K.
    Vnitr Lek; 2007 Apr 09; 53(4):364-70. PubMed ID: 17578167
    [Abstract] [Full Text] [Related]

  • 10. [Role of beta-blockers in the treatment of arterial hypertension].
    Goose P, Dallocchio M.
    Ann Cardiol Angeiol (Paris); 1989 Feb 09; 38(2):115-9. PubMed ID: 2565100
    [Abstract] [Full Text] [Related]

  • 11. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B.
    Herz; 1982 Jun 09; 7(3):168-78. PubMed ID: 6124492
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular protection using beta-blockers: a critical review of the evidence.
    Bangalore S, Messerli FH, Kostis JB, Pepine CJ.
    J Am Coll Cardiol; 2007 Aug 14; 50(7):563-72. PubMed ID: 17692739
    [Abstract] [Full Text] [Related]

  • 13. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW.
    Clin Ther; 2009 Mar 14; 31(3):447-62. PubMed ID: 19393838
    [Abstract] [Full Text] [Related]

  • 14. Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension?
    Kountz DS.
    Postgrad Med; 2009 Jan 14; 121(1):14-24. PubMed ID: 19179810
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative properties of various beta-blockers, with an outlook to the future.
    van Zwieten PA.
    Clin Physiol Biochem; 1990 Jan 14; 8 Suppl 2():18-27. PubMed ID: 1982758
    [Abstract] [Full Text] [Related]

  • 17. Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of beta-blockade.
    Teger-Nilsson AC, Larsson PT, Hjemdahl P, Olsson G.
    Circulation; 1991 Dec 14; 84(6 Suppl):VI72-7. PubMed ID: 1683612
    [Abstract] [Full Text] [Related]

  • 18. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B, Brilla C, Kruse T, Noll B, Bethge C.
    Herz; 1995 Dec 14; 20(6):370-89. PubMed ID: 8582697
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Beta-blockers in the management of hypertension: focus on nebivolol.
    Wojciechowski D, Papademetriou V.
    Expert Rev Cardiovasc Ther; 2008 Apr 14; 6(4):471-9. PubMed ID: 18402537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.